Feeding response to neuropeptide Y-related compounds in rats treated with Y5 receptor antisense or sense phosphothio-oligodeoxynucleotide
- PMID: 10405118
- DOI: 10.1016/s0031-9384(99)00031-1
Feeding response to neuropeptide Y-related compounds in rats treated with Y5 receptor antisense or sense phosphothio-oligodeoxynucleotide
Abstract
Neuropeptide Y (NPY), NPY 3-36 and pancreatic polypeptide (PP) increase short-term (2-h) food intake to varying degrees when given intracerebroventricularly (i.c.v.). Various Y receptor subtypes are proposed to participate in Y receptor ligand-induced stimulation of food intake. Here, we used an antisense phosphothio-oligodeoxynucleotide sequence (-5 relative to the initiating ATG) to the Y5 receptor subtype, which has been suggested to mediate NPY-induced feeding. Rats were treated with i.c.v. antisense or sense phosphothio-oligodeoxynucleotide for 3.5 days before NPY, NPY 3-36, or PP i.c.v. administration. The results show that antisense to the Y5 receptor had no effect on either spontaneous 2-h or NPY-, NPY 3-36-, or PP-stimulated 2-h food intake. However, there was a significant decrease relative to the sense control group in 10-h food intake following the initial 2-h feeding response to NPY (n = 10, p < 0.0001) or NPY 3-36 (n = 10, p < 0.05). The data suggest that the Y5 receptor has a modulatory role in the maintenance of feeding, but not as the critical receptor to confer for NPY and NPY 3-36 action on food intake.
Similar articles
-
Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides.Diabetes. 1997 Nov;46(11):1792-8. doi: 10.2337/diab.46.11.1792. Diabetes. 1997. PMID: 9356028
-
Central administration of Y5 receptor antisense decreases spontaneous food intake and attenuates feeding in response to exogenous neuropeptide Y.J Endocrinol. 1998 Nov;159(2):307-12. doi: 10.1677/joe.0.1590307. J Endocrinol. 1998. PMID: 9795372
-
Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice.Endocrinology. 2000 Mar;141(3):1011-6. doi: 10.1210/endo.141.3.7387. Endocrinology. 2000. PMID: 10698177
-
Role of hypothalamic neuropeptide Y in feeding and obesity.Neuropeptides. 1999 Oct;33(5):329-38. doi: 10.1054/npep.1999.0057. Neuropeptides. 1999. PMID: 10657510 Review.
-
Neuropeptide Y Y5 receptor antagonists as anti-obesity drugs.Curr Opin Investig Drugs. 2003 Oct;4(10):1198-204. Curr Opin Investig Drugs. 2003. PMID: 14649211 Review.
Cited by
-
The neuropeptide-Y Y5 receptor antagonist L-152,804 decreases alcohol self-administration in inbred alcohol-preferring (iP) rats.Alcohol. 2005 Jul;36(3):179-86. doi: 10.1016/j.alcohol.2005.10.001. Alcohol. 2005. PMID: 16377459 Free PMC article.
-
Suppression of third ventricular NPY-elicited feeding following medullary reticular formation infusions of muscimol.Behav Neurosci. 2010 Apr;124(2):225-33. doi: 10.1037/a0018928. Behav Neurosci. 2010. PMID: 20364882 Free PMC article.
-
Neuroendocrine regulation of eating behavior.J Endocrinol Invest. 2002 Nov;25(10):836-54. doi: 10.1007/BF03344047. J Endocrinol Invest. 2002. PMID: 12508946 Review.
-
The role of gastrointestinal hormones in the pathogenesis of obesity and type 2 diabetes.Prz Gastroenterol. 2014;9(2):69-76. doi: 10.5114/pg.2014.42498. Epub 2014 May 5. Prz Gastroenterol. 2014. PMID: 25061485 Free PMC article. Review.
-
Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.Philos Trans R Soc Lond B Biol Sci. 2006 Jul 29;361(1471):1159-85. doi: 10.1098/rstb.2006.1855. Philos Trans R Soc Lond B Biol Sci. 2006. PMID: 16874931 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous